SEC Insider Transactions from Dube Michael P.

Last updated: 2026-03-14 11:54 UTC | Total transactions: 8

Michael P. Dube, VP and Chief Accounting Officer at Intellia Therapeutics ($NTLA), made three open market sales of company shares over the past year, totaling about $85,000. His most recent sale occurred on January 5, 2026. He recorded no open market purchases. Among 11,700 insiders with sales, Dubes activity ranks 9,796th, well below the average sale amount of 8.6 million across 6.4 transactions per seller.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 1, 2026 Intellia Therapeutics, Inc. $NTLA Dube Michael P VP, Chief Accounting Officer A Common Stock 17250 $0.00 69,527.0000 115,829,926 33.00% 0.01%
Jan. 5, 2026 Intellia Therapeutics, Inc. $NTLA Dube Michael P VP, Chief Accounting Officer S Common Stock 2989 $9.21 52,277.0000 115,829,926 5.41% 0.00%
Oct. 1, 2025 Intellia Therapeutics, Inc. $NTLA Dube Michael P VP, Chief Accounting Officer S Common Stock 1871 $17.38 55,266.0000 103,517,460 3.27% 0.00%
July 2, 2025 Intellia Therapeutics, Inc. $NTLA Dube Michael P VP, Chief Accounting Officer S Common Stock 2503 $9.95 57,137.0000 103,517,460 4.20% 0.00%
March 1, 2025 Intellia Therapeutics, Inc. $NTLA Dube Michael P VP, Chief Accounting Officer A Common Stock 14000 $0.00 59,640.0000 103,517,460 30.67% 0.01%
Jan. 3, 2025 Intellia Therapeutics, Inc. $NTLA Dube Michael P VP, Chief Accounting Officer S Common Stock 1372 $12.18 45,640.0000 0 2.92% 0.00%
Oct. 2, 2024 Intellia Therapeutics, Inc. $NTLA Dube Michael P VP, Chief Accounting Officer S Common Stock 2012 $19.01 47,012.0000 0 4.10% 0.00%
July 1, 2024 Intellia Therapeutics, Inc. $NTLA Dube Michael P VP, PAO and Interim PFO A Common Stock 17801 $0.00 49,024.0000 0 57.01% 0.00%